These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7430335)

  • 41. Cefaclor in the treatment of uncomplicated gonococcal urethritis.
    Harrison WO
    Postgrad Med J; 1979; 55 Suppl 4():85-7. PubMed ID: 121455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Apr; 13(4):584-8. PubMed ID: 666290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility.
    Zhang SX; Parisian F; Yau Y; Fuller JD; Poutanen SM; Richardson SE
    J Clin Microbiol; 2007 Nov; 45(11):3762-3. PubMed ID: 17728468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I.
    Cleary TJ; Maurer D
    Antimicrob Agents Chemother; 1978 May; 13(5):837-41. PubMed ID: 248270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J; Levison ME
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
    Sinai R; Hammerberg S; Marks MI; Pai CH
    Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study.
    Leuenberger P; Vrantchev S
    Eur J Clin Microbiol; 1983 Feb; 2(1):11-6. PubMed ID: 6341045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two new oral cephalosporins.
    Med Lett Drugs Ther; 1979 Oct; 21(21):85-7. PubMed ID: 502965
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
    Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
    Smialowicz CR
    Clin Ther; 1982; 5(2):113-9. PubMed ID: 7159894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.
    Rotschafer J; Crossley K; Zaske D; Viste R
    Urology; 1979 Sep; 14(3):233-6. PubMed ID: 384643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of United States clinical trial isolates to cefprozil and cefaclor.
    Kessler RE; Fung-Tomc JC
    Diagn Microbiol Infect Dis; 1994 Feb; 18(2):129-32. PubMed ID: 8062532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global surveillance of bacterial susceptibility to cefaclor: 1988-1990.
    Preston DA
    Clin Ther; 1993; 15(1):88-96. PubMed ID: 8458058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
    Nies BA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A simple disk diffusion test to identify beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae--application of cephalexin, cefsulodin and cefaclor disks].
    Endo R; Yamane N; Tamayose MH; Uchibori KK; Nakasone I
    Rinsho Byori; 2010 Oct; 58(10):963-71. PubMed ID: 21077285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity and beta-lactamase stability of LY163892.
    Pelosi E; Fontana R
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):549-51. PubMed ID: 3141170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)].
    Schröter G; Loch R
    Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disk diffusion susceptibility tests: need for laboratory-specific breakpoints.
    Manninen R; Eerola E; Huovinen P
    Scand J Infect Dis; 1995; 27(1):45-9. PubMed ID: 7784813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of cefaclor on the pharmacokinetics of theophylline.
    Bachmann K; Schwartz J; Forney RB; Jauregui L
    Ther Drug Monit; 1986; 8(2):151-4. PubMed ID: 3726927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.